[Update on chemotherapy for bladder cancer. Update 2010]

M M Heck; J E Gschwend; M Retz

doi:10.1007/s00120-010-2380-y

[Update on chemotherapy for bladder cancer. Update 2010]

Urologe A. 2010 Oct;49(10):1294-300. doi: 10.1007/s00120-010-2380-y.

[Article in German]

Authors

M M Heck¹, J E Gschwend, M Retz

Affiliation

¹ Urologische Klinik und Poliklinik , Klinikum rechts der Isar, Technische Universität München, München.

PMID: 20859610
DOI: 10.1007/s00120-010-2380-y

Abstract

This review summarizes results of neoadjuvant and adjuvant trials for locally advanced bladder cancer as well as data on systemic chemotherapy for metastatic urothelial cancer. Increasing attention has been drawn to targeted cancer therapies in the treatment of urothelial cancer in recent years. In future, molecular profiling will play a major role as a means to tailor individual therapy.

Publication types

English Abstract
Review

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / administration & dosage*
Antineoplastic Combined Chemotherapy Protocols / adverse effects
Carcinoma, Transitional Cell / drug therapy*
Carcinoma, Transitional Cell / genetics
Carcinoma, Transitional Cell / mortality
Carcinoma, Transitional Cell / pathology
Chemotherapy, Adjuvant
Disease-Free Survival
Drug Delivery Systems*
Humans
Neoadjuvant Therapy*
Neoplasm Staging
Randomized Controlled Trials as Topic
Treatment Outcome
Urinary Bladder Neoplasms / drug therapy*
Urinary Bladder Neoplasms / genetics
Urinary Bladder Neoplasms / pathology